profit from every $100 of sales.
$0$100
Strata Critical Medical
$6.05+8.81% today
+36.6% in 1 year
1-year low $4.031-year high $6.47
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $13.07 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Strata Critical Medical sold, what it kept, and what it did with the cash.
Sales went from $146 million in 2022 to $197 million in 2025, with $41.3 million of profit last year.
SalesProfit
Strata Critical Medical vs. similar companies
Strata Critical Medical grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Strata Critical Medical | 13.1× · Cheap | ||
 United Airlines Holdings | 11.7× · Cheap | ||
 Ryanair Holdings | 13.1× · Cheap | ||
 Southwest Airlines | 51.4× · Expensive | ||
 LATAM Airlines Group | 9.9× · Cheap |
AI analysis
An AI analyst reads Strata Critical Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 146 | 225 | 147 | 197 | |
| 22 | 42 | 30 | 41 | |
| -54 | -68 | -23 | -22 | |
| -48 | -61 | -17 | -14 | |
| -27 | -56 | -27 | 41 | |
| -0.38 | -0.76 | -0.34 | 0.48 | |
| 15.2% | 18.7% | 20.2% | 20.9% | |
| -36.6% | -30.3% | -15.3% | -11.3% | |
| -18.7% | -24.9% | -18.6% | 21.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 325 | 295 | 257 | 325 |
| Cash | 41 | 28 | 16 | 31 |
| Total debt | 18 | 25 | 3 | 3 |
| Total liabilities | 51 | 61 | 35 | 46 |
| 274 | 234 | 222 | 279 | |
| 72 | 74 | 79 | 87 | |
| -14.4% | -20.8% | -7.9% | -6.3% | |
| -9.9% | -23.9% | -12.3% | 14.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -37 | -32 | -3 | -49 | |
| 1 | 2 | 33 | 11 | |
| -38 | -34 | -36 | -60 | |
| Dividends paid | – | – | – | – |
| – | 0 | 0 | 0 | |
| 8 | 13 | 20 | 18 |
Valuation
- 13.1×
- –
- –
- 1.9×
- 2.7×
- –
- –
- -11.1%
- 7.7%
- 0.0%
Profitability
- 20.9%
- -11.3%
- 21.0%
- -2.2%
- -4.9%
- -12.4%
- 19.0%
- 15.5%
- -4.9%
- 1.6%
Growth
- +10.5%
- –
- −68.7%
- –
- +4.1%
Financial health
- -2.0×
- 0.02
- 1.4%
- –
- 5.93
- 5.93
- 0.78
How it ranks in Industrials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 5%of 979
Bottom 4%of 984
Top 20%of 862
Top 33%of 983
Bottom 4%of 986
What analysts expect
- Average price target
- $7.25
- Range
- $7.25 – $7.25
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 0.03 | -0.04 | +175.0% |
| Mar 3, 2026 | -0.06 | 0.01 | −721.4% |
| Nov 10, 2025 | -0.06 | -0.02 | −200.0% |
| Aug 5, 2025 | -0.05 | -0.04 | −25.0% |
| May 12, 2025 | -0.04 | -0.11 | +63.6% |
| Mar 13, 2025 | -0.12 | -0.12 | +0.0% |
| Nov 12, 2024 | -0.03 | -0.06 | +50.0% |
| Aug 7, 2024 | -0.06 | -0.06 | +0.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
41No pass
Benjamin Graham
67Pass
Philip Fisher
42No pass
Peter Lynch
77Pass
Joel Greenblatt
19No pass
Charlie Munger
41No pass
Terry Smith
40No pass
Questions about Strata Critical Medical
Is Strata Critical Medical a good stock to buy?
A strong, very profitable business, and the price looks low. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Strata Critical Medical AI analysis
What does Strata Critical Medical do?
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. It is in Airlines, Airports & Air Services.
Does Strata Critical Medical pay a dividend?
No. Strata Critical Medical does not pay a dividend at the moment.
Is Strata Critical Medical stock halal?
Yes. Strata Critical Medical passes our halal screen: its business is permitted and its debt is 0.6% of its market value, under the 30% limit. How we check
How has Strata Critical Medical stock done over the past year?
Up 36.6% over the past twelve months, to $6.05. It traded between $4.03 and $6.47 and is 6.5% below its high.
Who are Strata Critical Medical's competitors?
The largest listed companies in the same industry are United Airlines Holdings, Ryanair Holdings, Southwest Airlines and LATAM Airlines Group. The peers table on this page compares their profit, growth and price with Strata Critical Medical's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.